What is OrbusNeich?
Founded in 2000, OrbusNeich stands as a global pioneer in the provision of life-changing vascular solutions. The company maintains an extensive portfolio of products that consistently set industry benchmarks in vascular intervention. Headquartered in Hong Kong, China, OrbusNeich leverages its deep technical expertise to address complex cardiovascular challenges, positioning itself as a critical player in the medical device landscape. Its market position is defined by a commitment to clinical excellence and the continuous evolution of its product pipeline, which serves healthcare providers and patients worldwide.
How much funding has OrbusNeich raised?
OrbusNeich has raised a total of $200M across 1 funding round:
Unspecified
$200M
Unspecified (2021): $200M with participation from Shenzhen Capital Group, CCB International, and China International Capital
Key Investors in OrbusNeich
Shenzhen Capital Group
A prominent venture capital firm based in China that focuses on supporting high-growth technology and healthcare enterprises through strategic equity investments.
CCB International
An investment services subsidiary of China Construction Bank Corporation, specializing in pre-IPO, IPO, and post-IPO financing, as well as direct investment and asset management.
China International Capital
A leading full-service investment bank established in 1995, providing comprehensive financial services including investment banking, wealth management, and direct investment across global markets.
What's next for OrbusNeich?
With the successful closure of this major strategic investment, OrbusNeich is well-positioned to execute its next phase of growth. The company is expected to prioritize the scaling of its manufacturing capabilities and the expansion of its commercial reach into emerging markets. Furthermore, the infusion of capital will likely support the advancement of its clinical trial programs and the integration of next-generation technologies into its existing vascular intervention portfolio. By maintaining a focus on innovation and operational efficiency, OrbusNeich aims to sustain its competitive advantage and drive long-term value for its stakeholders in the rapidly evolving healthcare ecosystem.
See full OrbusNeich company page
